Skip to main content

Table 1 Subjects’ characteristic

From: A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention

 ElectrophysiologyReflexesVibration sense 
PatientSexHeight (cm)Weight (kg)Age (years)DiagnosisStatusMonths since initial diagnosis (n)Cycles of neurotoxic drugs (n)NCV N.tibialis (m/s)APA N.suralis (μV)Achilles tendonPatellar tendonrightleftNtxS (score)
1m18212555–59B-NHLPartial remission18514321.76/86/834
2m1828065–69Multiple myelomaStable disease583400+5.5/80.5/829
3f1618660–64Multiple myelomaRelapse827286.054/83.5/824
4f1626065–69Breast cancerStable disease6619493.55+5/85/823
5m1808060–64Multiple myelomaStable disease84391.55(−)(−)0.5/81.5/834
6m1679260–64Breast cancerStable disease195254000.5/84/814
7m1766465–69Rectal cancerProgressive disease118793700/80/823
8m18810740–44Germ cell cancerComplete remission6644214/80/822
mean ± SDm:f
6:2
174.8 ± 10.186.8 ± 21.560.8 ± 8.7  97.3 ± 64.823.3 ± 24.934.4 ± 14.91.7 ± 2.1  3.2 ± 2.52.6 ± 2.425.4 ± 6.3
Healthy control subjects
mean ± SDm:f
9:6
17.0 ± 9.178.0 ± 6.359.6 ± 10.0           
  1. APA action potential amplitude (normal values: ≥6 μV), B-NHL B-Non Hodgkin Lymphoma, f female, m male, NCV nerve conduction velocity (normal values: ≥41 m/s), NtxS neurotoxicity subscale of FACT/GOG (Functional Assessment of Cancer Therapy/Gynaecology Oncology Group) scored from 0 (severe symptoms) – 44 (no symptoms); SD, standard deviation; “-”, no reflex; “(−)”, reduced reflex; “+”, normal reflex